News Focus
News Focus
Followers 92
Posts 7491
Boards Moderated 1
Alias Born 09/18/2009

Re: None

Tuesday, 11/18/2025 4:13:57 PM

Tuesday, November 18, 2025 4:13:57 PM

Post# of 110
I think we will see a merger announced between Humanigen and Sanofi (HSAI).

I'm not sure of how the UPenn agreement with PolyMedix is relevant. PolyMedix went bankrupt after developing Brilacidin. The IP rights went to our predecessor company and now IPIX has the IP. Or, more accurately, perhaps I should say they HAD the IP. I think the Brilacidin IP has been sold to HSAI.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today